![]() Data from this trial were presented at multiple medical society meetings, including the North American Neuromodulation Society (NANS) and the International Neuromodulation Society (INS) earlier this year. Even at the highest settings, the systems were still in use only 25% of the time, the company noted. Proclaim XR also uses Apple mobile devices and Bluetooth wireless technology.Ībbott developed the system based on positive results from a study that showed all 24 enrolled patients on a low-energy BurstDR dosing program experienced pain relief with less than six hours of battery use per day, while approximately half of those patients achieved pain relief with the lowest effective dose (less than two hours of battery use per day). ![]() ![]() The low doses extend the system’s battery life, the company said. The Proclaim XR neurostimulation system couples low-energy therapy with a low-dosing protocol to provide pain relief and preserve its battery.Ībbott said its BurstDR stimulation waveform was designed to mimic natural patterns found in the brain and to use low doses of mild electrical pulses to change pain signals as they travel from the spinal cord to the brain. Abbott (NYSE: ABT) announced today that the FDA has approved its low-dose, recharge-free spinal cord stimulation system with up to 10-year battery life for people in chronic pain.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |